StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Oilersgoforcupon Dec 04, 2020 1:33pm

96 Views

Post# 32038237

RE:RE:The competition had been launched! Where's Aristotle???

KEY WORKS FOR ALL THE NEWBIE's

Galleri is expected to be commercially available in the U.S. in 2021. It is currently available under investigational use in GRAILs first interventional study, PATHFINDER, where it is being used to guide clinical care.

They got nothing with out finalizing there clinical trials. Just a bunch of Buzz words in the New's Release to get you excited. Plus Grail's Clinical trials won't be completed till mid next year, then you PRAY for FDA APPROVAL !!!

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025